Leveragen has announced a strategic partnership with Moonlight Bio, targeting the development of T-cell therapies for ...

Students with a score of four or five on the AP Biology exam could bypass the department’s introductory courses and fulfill ...

The Phase III trial builds on findings from prior findings that indicated Anktiva can restore T-cell function and improve overall survival in patients with advanced of metastatic non-small cell lung ...

Twenty-two million accelerates Maine’s R&D support of natural polymers and other wood fiber bio-products for startups and ...

Debut, the biotech beauty leader, announced today the launch of BeautyORB™, an AI-powered innovation engine that provides a ...

BHUBANESWAR: Union secretary of Department of Biotechnology (DBT) Prof Rajesh Gokhale on Friday inaugurated a ...

Pegozafermin. It has two Phase 3 trials: one for MASH and the other for SHTG. See why I continue to rate ETNB stock a buy.

A graduate of Stanford University's prestigious EENT Innovation Biodesign program in 2019, Diag-Nose.io is redefining ...

One to twenty-four samples can be processed in a single run to isolate free-circulating DNA from fetal-originated DNA in ...

In the intricate tapestry of nature, few threads are as overlooked—yet vital—as insects. For Professor Michal Segoli of ...

The popularity and accessibility of advanced aesthetic treatments have boomed in recent years, with 2025 set to be a big year ...

Iovance Biotherapeutics (IOVA -0.96%), a small-cap biotech company, has an innovative approach to treating cancer that relies ...